Recent advances in nanotherapeutics for neurological disorders

A Vashist, P Manickam, AD Raymond… - ACS Applied Bio …, 2023 - ACS Publications
Neurological disorders remain a significant health and economic burden worldwide.
Addressing the challenges imposed by existing drugs, associated side-effects, and immune …

Gold nanoparticles in neurological diseases: A review of neuroprotection

MC Chiang, YP Yang, CJB Nicol, CJ Wang - International Journal of …, 2024 - mdpi.com
This review explores the diverse applications of gold nanoparticles (AuNPs) in neurological
diseases, with a specific focus on Alzheimer's disease (AD), Parkinson's disease (PD), and …

Dual-layers Raman reporter-tagged Au@ Ag combined with core-satellite assemblies for SERS detection of Zearalenone

L Yin, T You, M Arslan, HR El-Seedi, Z Guo, X Zou… - Food Chemistry, 2023 - Elsevier
Zearalenone (ZEN) is a prevalent mycotoxin identified in corn. A SERS-based
immunosensor by constructing core-satellite assemblies was developed for ZEN detection …

Introducing high-performance star-shaped bimetallic nanotags into SERS aptasensor: An ultrasensitive and interference-free method for chlorpyrifos detection

H Ma, L Hu, F Ding, J Liu, J Su, K Tu, J Peng… - Biosensors and …, 2024 - Elsevier
Implementation of cost-effective, reliable, and efficient technologies for the sensitive, rapid,
and accurate detection of pesticide residues in agriproducts presents a promising solution to …

Gold and silver nanoparticles in Alzheimer's and Parkinson's diagnostics and treatments

E Scarpa, M Cascione, A Griego, P Pellegrino… - Ibrain, 2023 - Wiley Online Library
Neurodegenerative diseases (NDs) impose substantial medical and public health burdens
on people worldwide and represent one of the major threats to human health. The …

Nanomaterials that Aid in the Diagnosis and Treatment of Alzheimer's Disease, Resolving Blood–Brain Barrier Crossing Ability

Q Song, J Li, T Li, HW Li - Advanced Science, 2024 - Wiley Online Library
As a form of dementia, Alzheimer's disease (AD) suffers from no efficacious cure, yet AD
treatment is still imperative, as it ameliorates the symptoms or prevents it from deteriorating …

[HTML][HTML] Recent developments in selective therapeutic targeting of functionalized nanomaterials to neurovascular units in overcoming the gaps in neurovascular …

S Goswami, NK Isaev, AB Salmina, SVS Rana… - Brain Disorders, 2024 - Elsevier
Neurodegenerative disorders are difficult to treat because of this natural barrier in the brain.
Moreover, neurovascular units seem to be essential targets/mediators of the nervous system …

Peptide-metal nanohybrids (PMN): Promising entities for combating neurological maladies

A Kour, HS Panda, IR Singh, A Kumar… - Advances in Colloid and …, 2023 - Elsevier
Nanotherapeutics are gaining traction in the modern scenario because of their unique and
distinct properties which separate them from macro materials. Among the nanoparticles …

Dendrimers in the management of Alzheimer's disease

C Modi, BG Prajapati, S Singh, A Singh… - Alzheimer's Disease and …, 2024 - Elsevier
Alzheimer's disease (AD) is a progressive neurological disorder that affects the brain and
leads to decline in cognitive function, memory, thinking, behavior. Alzheimer's disease is the …

Virus-Shaped Mesoporous Silica Nanostars to Improve the Transport of Drugs across the Blood–Brain Barrier

A Pinna, I Ragaisyte, W Morton… - … applied materials & …, 2024 - ACS Publications
Conditions affecting the brain are the second leading cause of death globally. One of the
main challenges for drugs targeting brain diseases is passing the blood–brain barrier (BBB) …